DDIT4 and cancer: As reduced anabolic signalling also contributes to muscle atrophy in cancer cachexia, we tested the impact of AdipoRon on REDD‐1 expression (Ddit4), an inhibitor of the mammalian target of rapamycin complex 1 (mTORC1), which is under the positive transcriptional control of glucocorticoids.